- Issuer ticker
-
RXRX
- Reported as of
-
16 Nov 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
18 Nov 2026, 17:15:26 UTC
Filing notes and source
Key filing fact
David Hallett filed Form 4 for RECURSION PHARMACEUTICALS, INC. (RXRX) on 18 Nov 2026.
Key facts
- This page summarizes David Hallett's Form 4 filing for RECURSION PHARMACEUTICALS, INC. (RXRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Nov 2026, 17:15.
Change
- Previous filing in this sequence was filed on 18 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002006495
Primary reporting owner
Hallett David
- Relationship
-
Chief Scientific Officer
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RXRX
transaction
Class A Common Stock
Tax liability
- Transaction value
- Shares
- -26,657
- Change %
- -2.6%
- Price
-
$3.18*
- Shares after
- 1,017,180
- Date
- 16 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote